Literature DB >> 6661283

The effects of dorsal bundle lesions on serial and trace conditioning.

E Tsaltas, G C Preston, J A Gray.   

Abstract

The performance of rats with neurotoxic lesions of the dorsal ascending noradrenergic bundle (DB) was compared with that of sham-operated control animals under two behavioural conditions. Animals with DB lesions were slower than controls to acquire a classically-conditioned emotional response (conditioned suppression) with a trace interval interposed between the clicker conditioned stimulus (CS) and the shock reinforcer. However, if the latter half of the trace interval was filled by a second stimulus, a light, the DB-lesioned animals acquired conditioned suppression to the clicker faster than did controls under the same conditions. These results are discussed in terms of the attentional theory of DB function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661283     DOI: 10.1016/0166-4328(83)90040-2

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  4 in total

1.  Trace fear conditioning in mice.

Authors:  Joaquin N Lugo; Gregory D Smith; Andrew J Holley
Journal:  J Vis Exp       Date:  2014-03-20       Impact factor: 1.355

2.  Extinguishing trace fear engages the retrosplenial cortex rather than the amygdala.

Authors:  Janine L Kwapis; Timothy J Jarome; Jonathan L Lee; Marieke R Gilmartin; Fred J Helmstetter
Journal:  Neurobiol Learn Mem       Date:  2013-09-18       Impact factor: 2.877

3.  Dorsal bundle lesions do not affect latent inhibition of conditioned suppression.

Authors:  E Tsaltas; G C Preston; J N Rawlins; G Winocur; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Transcriptome Profile in Hippocampus During Acute Inflammatory Response to Surgery: Toward Early Stage of PND.

Authors:  Xuwu Xiang; Yang Yu; Xiaodong Tang; Manli Chen; Yueying Zheng; Shengmei Zhu
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.